Drug Shortage Report for VIMPAT

Last updated on 2019-06-26 History
Report ID 82479
Drug Identification Number 02357666
Brand name VIMPAT
Common or Proper name VIMPAT IV 10mg/mL
Company Name UCB CANADA INC
Active Ingredient(s) LACOSAMIDE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 5 x 20mL vials/carton
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-05-15
Actual start date 2019-05-20
Estimated end date 2019-06-17
Actual end date 2019-06-21
Shortage status Resolved
Updated date 2019-06-26
Company comments
Health Canada comments
Contact Address 2060 WINSTON PARK DRIVE, 401
OAKVILLE, ONTARIO
CANADA L6H 5R7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2019-06-26 French Compare
v6 2019-06-26 English Compare
v5 2019-05-21 French Compare
v4 2019-05-21 English Compare
v3 2019-05-16 English Compare
v2 2019-04-26 French Compare
v1 2019-04-26 English Compare